文献速递新发突发、热带与寄生虫病

疟疾疫苗试验中与中重度不良事件相关的细胞因子

Cytokines Associated With Moderate and Severe Adverse Events During a Sporozoite Malaria Vaccine Trial With Controlled Human Malaria Infection.
PubMed 文献 · J Infect Dis · 2026-01-01

该研究利用一项不良事件发生率高于预期的疟疾疫苗试验,通过频繁采样分析不良事件相关的细胞因子谱。发现发生中重度不良事件当天白介素-6升高。作者呼吁加强不良事件免疫应答研究以识别系统性反应原性生物标志物。

要点

  • 中重度不良事件发生当天白介素-6升高。
  • 利用不良事件率高于预期的疫苗试验开展细胞因子分析。
  • 需进一步研究不良事件相关免疫应答以识别生物标志物。

核心结论

  • 中重度不良事件发生当天白介素-6升高。

研究设计与样本

  • 利用一项不良事件发生率高于预期的疟疾疫苗试验,进行频繁采样以分析不良事件相关细胞因子谱。

主要发现

  • 发生中重度不良事件当天白介素-6升高。

临床怎么用

  • 提示白介素-6或可作为系统性反应原性的候选生物标志物,但需进一步验证。

局限性

  • 原文未明确报告样本量、具体细胞因子检测方法及统计阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ensuring the safety and efficacy of candidate vaccines is critical. Although mechanisms underpinning protective immune responses to malaria vaccines are frequently investigated, immune responses correlating with moderate and severe adverse events (AEs) are rarely examined. Here, we leverage a malaria vaccine trial with a higher-than-expected AE rate and frequent sampling to investigate cytokine profiles associated with AEs. We found that Interleukin-6 was elevated on days in which individuals experienced moderate and severe AEs. More research on immune responses associated with AEs is warranted in order to identify biomarkers associated with systemic reactogenicity and accelerate vaccine development.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Jatt LP, Gillespie KM, Van P, et al. Cytokines Associated With Moderate and Severe Adverse Events During a Sporozoite Malaria Vaccine Trial With Controlled Human Malaria Infection. J Infect Dis. 2026. PMID: 40811667. doi:10.1093/infdis/jiaf435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。